FIBROGEN, INC.

FGEN
Delayed Quote. Delayed  - 01/25 04:00:00 pm
49.59USD +4.27%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 257217
EBITDA1 -78,2-130
Operating profit (EBIT)1 -89,3-161
Operating Margin -34,8%-74,4%
Pre-Tax Profit (EBT)1 -76,6-160
Net income1 -77,0-158
Net margin -30,0%-73,0%
EPS2 -0,89-1,69
Dividend per Share2 --
Last update 03/02/202012/25/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt --
Net Cash position --
Leverage (Debt / EBITDA) --
Free Cash Flow1 -84,5-83,7
ROE (Net Profit / Equities) --29,3%
Shareholders' equity1 -539
ROA (Net Profit / Asset) --
Assets1 --
Book Value Per Share --
Cash Flow per Share2 -0,69
Capex1 5,762,25
Capex / Sales 2,25%1,04%
Last update 03/02/202001/25/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 4 513 M $ -
Valuation 2020e 2021e
P/E ratio (Price / EPS) -29,4x -53,2x
Capitalization / Revenue 20,8x 9,47x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) -74,4% -25,5%
Operating Leverage (Delta EBIT / Delta Sales) -5,20x 0,21x
Net Margin (Net Profit / Revenue) -73,0% -14,0%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) -29,3% -
Rate of Dividend - -
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   1,04% 0,78%
Cash Flow / Sales 28,9% -2,70%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend